Stock AFT AFT PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights AFT Pharmaceuticals Limited

Equities

AFT

NZAFTE0001S4

End-of-day quote New Zealand S.E.
Other stock markets
 23:00:00 20/06/2024 BST 		5-day change 1st Jan Change
2.85 NZD -6.25% Intraday chart for AFT Pharmaceuticals Limited -9.81% -18.57%
06-04 New Zealand Shares Flat; Scott Technology Adds Meat Cutter to Brand Portfolio MT
06-03 AFT Pharmaceuticals Partners with Alexso to Bring Pain Relief Drug to US Market MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
New Zealand Shares Flat; Scott Technology Adds Meat Cutter to Brand Portfolio
MT
AFT Pharmaceuticals Partners with Alexso to Bring Pain Relief Drug to US Market
MT
AFT Pharmaceuticals Limited to Launch Maxigesic Rapid in the United States
CI
AFT Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
AFT Pharmaceuticals' Net Profit Climbs 46% in Fiscal 2024; Dividend Declared
MT
AFT Pharmaceuticals Limited Announces Ordinary Dividend for the Twelve Months Ended Mach 31, 2024, Payable on July 4, 2024
CI
AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV
MT
AFT Pharmaceuticals Limited Licenses Maxigesic IV in Brazil
CI
AFT Pharmaceuticals, Massey Ventures, Gillies McIndoe Research Institute Partner to Develop Topical Scar Treatment
MT
AFT Pharmaceuticals Limited, Massey Ventures, Gilles Mcindoe Research Institute to Develop Scar Treatment
CI
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals
MT
Aft Expands Its Co-Operation with Hikma Pharmaceuticals
CI
AFT Pharmaceuticals Boosts Operating Profit Guidance for Fiscal Year 2024
MT
AFT Pharmaceuticals Limited Updates Earnings Guidance for the Fiscal Year 2024
CI
AFT Pharmaceuticals' Licensee Launches Pain Relief Medication in US; Shares Rise 4%
MT
AFT Pharmaceuticals Ties Up with Belgian Firm to Develop Skin Medication
MT
Hyloris Pharmaceuticals SA Enters into Partnership with AFT Pharmaceuticals to Develop a Novel Mucoadhesive Film for the Treatment of Vulvar Lichen Sclerosus
CI
AFT Pharmaceuticals Ties Up with Hyloris to Develop Burning Mouth Syndrome Treatment Candidate
MT
AFT Pharmaceuticals Limited Enters into Partnership with Hyloris Pharmaceuticals
CI
AFT Pharmaceuticals Limited Reaffirms Earnings Guidance for the Fiscal Year 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AFT Stock
  4. News AFT Pharmaceuticals Limited
  5. Highlights